Best-in-Class and/or First-in-Class Therapeutics
We invest in cutting-edge science with the potential to deliver best-in-class and/or first-in-class therapeutics that transform patient lives. While primarily focused on therapeutics, we will also selectively fund medical device companies advancing transformative technology.
Oncology, Neurology & Immunology
Grounded by these four pillars, Red Tree Venture Capital aims to be the partner-of-choice for pioneering West Coast academics and entrepreneurs looking to create and build world-class life science companies.
We actively partner with scientific thought-leaders to collaboratively identify and advance breakthroughs that transform patient lives. As part of this commitment, we place a high priority on serving as lead or co-lead investor in our deals, as well as sitting on the boards of our portfolio companies.